SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.

P, Mlcochova; SA, Kemp; MS, Dhar; G, Papa; B, Meng; IATM, Ferreira; R, Datir; DA, Collier; A, Albecka; S, Singh; R, Pandey; J, Brown; J, Zhou; N, Goonawardane; S, Mishra; C, Whittaker; T, Mellan; R, Marwal; M, Datta; S, Sengupta; K, Ponnusamy; VS, Radhakrishnan; A, Abdullahi; O, Charles; P, Chattopadhyay; P, Devi; D, Caputo; T, Peacock; C, Wattal; N, Goel; A, Satwik; R, Vaishya; M, Agarwal; A, Mavousian; JH, Lee; J, Bassi; C, Silacci-Fegni; C, Saliba; D, Pinto; T, Irie; I, Yoshida; WL, Hamilton; K, Sato; S, Bhatt; S, Flaxman; LC, James; D, Corti; L, Piccoli; WS, Barclay; P, Rakshit; A, Agrawal; RK, Gupta

doi:10.1038/s41586-021-03944-y

Public

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.

Shared by NobleBlocks on Sep 6, 2021 • 12:00 AM UTC

Authors:

Mlcochova P

Kemp SA

Dhar MS

Abstract

The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in the state of Maharashtra in late 2020 and spread throughout India, outcompeting pre-existing lineages including B.1.617.1 (Kappa) and B.1.1.7 (Alpha)1. In vitro, B.1.617.2 is sixfold...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!